Reduced systemic bicyclo-prostaglandin-E 2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemia

American Journal of Hematology

Volumn 87, Issue 8, 2012, Pages 782-789

  Anyona, Samuel B ^a,b,c   Kempaiah, Prakasha ^a   Raballah, Evans ^a,b   Davenport, Gregory C ^a   Were, Tom ^a,b   Konah, Stephen N ^a   Vulule, John M ^d   Hittner, James B ^e   Gichuki, Charity W ^b   Ong'echa, John M ^a   Perkins, Douglas J ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b KENYATTA UNIVERSITY   (Kenya)

^c MASENO UNIVERSITY   (Kenya)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^e Department of Teacher Education and Department of Sociology and Anthropology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOOXYGENASE 2; HEMOZOIN; PROSTAGLANDIN E2;

ANEMIA; ARTICLE; BRAIN MALARIA; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSERYTHROPOIESIS; FEMALE; HUMAN; IN VITRO STUDY; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALARIA; MALE; MONOCYTE; PARASITEMIA; PHAGOCYTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANEMIA; CHILD, PRESCHOOL; CREATININE; CYCLOOXYGENASE 2; DINOPROSTONE; ERYTHROPOIESIS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMEPROTEINS; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MONOCYTES; PARASITEMIA; PHAGOCYTOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84864009695     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23253     Document Type: Article

References (93)

1. World Health Organization. World Malaria Report 2009. Geneva: World Health Organization; 2009.
2. Rowe JA, Opi DH, Williams TN. Blood groups and malaria: Fresh insights into pathogenesis and identification of targets for intervention. Curr Opin Hematol 2009; 16: 480-487.
3. Obonyo CO, Vulule J, Akhwale WS, et al. In-hospital morbidity and mortality due to severe malarial anemia in western Kenya. Am J Trop Med Hyg 2007; 77: 23-28.
4. Ong'echa JM, Keller CC, Were T, et al. Parasitemia, anemia, and malarial anemia in infants and young children in a rural holoendemic Plasmodium falciparum transmission area. Am J Trop Med Hyg 2006; 74: 376-385.
5. Zucker JR, Perkins BA, Jafari H, et al. Clinical signs for the recognition of children with moderate or severe anaemia in western Kenya. Bull World Health Organ 1997; 75 ( Suppl 1): 97-102.
6. Dondorp AM, Angus BJ, Chotivanich K, et al. Red blood cell deformability as a predictor of anemia in severe falciparum malaria. Am J Trop Med Hyg 1999; 60: 733-737.
7. Dondorp AM, Chotivanich KT, Fucharoen S, et al. Red cell deformability, splenic function and anaemia in thalassaemia. Br J Haematol 1999; 105: 505-508.
8. Egan AF, Fabucci ME, Saul A, et al. Aotus New World monkeys: Model for studying malaria-induced anemia. Blood 2002; 99: 3863-3866.
9. Price RN, Simpson JA, Nosten F, et al. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg 2001; 65: 614-622.
10. Buffet PA, Safeukui I, Milon G, et al. Retention of erythrocytes in the spleen: A double-edged process in human malaria. Curr Opin Hematol 2009; 16: 157-164.
11. Abdalla S, Weatherall DJ, Wickramasinghe SN, et al. The anaemia of P. falciparum malaria. Br J Haematol 1980; 46: 171-183.
12. Phillips RE, Looareesuwan S, Warrell DA, et al. The importance of anaemia in cerebral and uncomplicated falciparum malaria: Role of complications, dyserythropoiesis and iron sequestration. Q J Med 1986; 58: 305-323.
13. Bassat Q, Guinovart C, Sigauque B, et al. Severe malaria and concomitant bacteraemia in children admitted to a rural Mozambican hospital. Trop Med Int Health 2009; 14: 1011-1019.
14. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005; 352: 39-47.
15. Davenport GC, Ouma C, Hittner JB, et al. Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1. Am J Hematol 2010; 85: 227-233.
16. Otieno RO, Ouma C, Ong'echa JM, et al. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS 2006; 20: 275-280.
17. Waitumbi JN, Kuypers J, Anyona SB, et al. Outpatient upper respiratory tract viral infections in children with malaria symptoms in Western Kenya. Am J Trop Med Hyg 2010; 83: 1010-1013.
18. Were T, Davenport GC, Hittner JB, et al. Bacteremia in Kenyan children presenting with malaria. J Clin Microbiol 2011; 49: 671-676.
19. Were T, Davenport GC, Yamo EO, et al. Naturally acquired hemozoin by monocytes promotes suppression of RANTES in children with malarial anemia through an IL-10-dependent mechanism. Microbes Infect 2009; 11: 811-819.
20. Novelli EM, Hittner JB, Davenport GC, et al. Clinical predictors of severe malarial anaemia in a holoendemic Plasmodium falciparum transmission area. Br J Haematol 2010; 149: 711-721.
21. Perkins DJ, Were T, Davenport GC, et al. Severe malarial anemia: Innate immunity and pathogenesis. Int J Biol Sci 2011; 7: 1427-1442.
22. Krugliak M, Zhang J, Ginsburg H. Intraerythrocytic Plasmodium falciparum utilizes only a fraction of the amino acids derived from the digestion of host cell cytosol for the biosynthesis of its proteins. Mol Biochem Parasitol 2002; 119: 249-256.
23. Liu J, Istvan ES, Gluzman IY, et al. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc Natl Acad Sci USA 2006; 103: 8840-8845.
24. Chou AC, Fitch CD. Heme polymerase: Modulation by chloroquine treatment of a rodent malaria. Life Sci 1992; 51: 2073-2078.
25. Egan TJ, Combrinck JM, Egan J, et al. Fate of haem iron in the malaria parasite Plasmodium falciparum. Biochem J 2002; 365: 343-347.
26. Goldberg DE, Slater AF. The pathway of hemoglobin degradation in malaria parasites. Parasitol Today 1992; 8: 280-283.
27. Pandey AV, Babbarwal VK, Okoyeh JN, et al. Hemozoin formation in malaria: A two-step process involving histidine-rich proteins and lipids. Biochem Biophys Res Commun 2003; 308: 736-743.
28. Slater AF. Malaria pigment. Exp Parasitol 1992; 74: 362-365.
29. Slater AF, Swiggard WJ, Orton BR, et al. An iron-carboxylate bond links the heme units of malaria pigment. Proc Natl Acad Sci USA 1991; 88: 325-329.
30. Keller CC, Hittner JB, Nti BK, et al. Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism. Mol Med 2004; 10: 45-54.
31. Habib A, Creminon C, Frobert Y, et al. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem 1993; 268: 23448-23454.
32. O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992; 89: 4888-4892.
33. Roy R, Polgar P, Wang Y, et al. Regulation of lysyl oxidase and cyclooxygenase expression in human lung fibroblasts: Interactions among TGF-β, IL-1β, and prostaglandin E. J Cell Biochem 1996; 62: 411-417.
34. Huang M, Stolina M, Sharma S, et al. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 1998; 58: 1208-1216.
35. Krysan K, Reckamp KL, Dalwadi H, et al. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 2005; 65: 6275-6281.
36. Machado ER, Carlos D, Lourenco EV, et al. Cyclooxygenase-derived mediators regulate the immunological control of Strongyloides venezuelensis infection. FEMS Immunol Med Microbiol 2010; 59: 18-32.
37. Pino MS, Nawrocki ST, Cognetti F, et al. Prostaglandin E2 drives cyclooxygenase-2 expression via cyclic AMP response element activation in human pancreatic cancer cells. Cancer Biol Ther 2005; 4: 1263-1269.
38. Ramaswamy K, Kumar P, He YX. A role for parasite-induced PGE2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni. J Immunol 2000; 165: 4567-4574.
39. Sato K, Torihashi S, Hori M, et al. Phagocytotic activation of muscularis resident macrophages inhibits smooth muscle contraction in rat ileum. J Vet Med Sci 2007; 69: 1053-1060.
40. Granstrom E, Hamberg M, Hansson G, et al. Chemical instability of 15-keto-13, 14-dihydro-PGE2: The reason for low assay reliability. Prostaglandins 1980; 19: 933-957.
41. Murphy RC, FitzGerald GA. Current approaches to estimation of eicosanoid formation in vivo. Adv Prostaglandin Thromboxane Leukot Res 1994; 22: 341-348.
42. Perkins DJ, Kremsner PG, Weinberg JB. Inverse relationship of plasma prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria. J Infect Dis 2001; 183: 113-118.
43. Perkins DJ, Hittner JB, Mwaikambo ED, et al. Impaired systemic production of prostaglandin E2 in children with cerebral malaria. J Infect Dis 2005; 191: 1548-1557.
44. Perkins DJ, Moore JM, Otieno J, et al. In vivo acquisition of hemozoin by placental blood mononuclear cells suppresses PGE2, TNF-α, and IL-10. Biochem Biophys Res Commun 2003; 311: 839-846.
45. Degousee N, Martindale J, Stefanski E, et al. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo. Circ Res 2003; 92: 757-764.
46. Jacobs-Helber SM, Ryan JJ, Sawyer ST. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells. Blood 2000; 96: 933-940.
47. Lasa M, Mahtani KR, Finch A, et al. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 2000; 20: 4265-4274.
48. Rocca B, Secchiero P, Celeghini C, et al. Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. Exp Hematol 2004; 32: 925-934.
49. Witt O, Sand K, Pekrun A. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 2000; 95: 2391-2396.
50. 2+-dependent K+ channel in human erythrocytes and alters cell volume and filterability. J Biol Chem 1996; 271: 18651-18656.
51. Zamai L, Secchiero P, Pierpaoli S, et al. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood 2000; 95: 3716-3724.
52. Bloland PB, Boriga DA, Ruebush TK, et al. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II.Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg 1999; 60: 641-648.
53. Okiro EA, Alegana VA, Noor AM, et al. Changing malaria intervention coverage, transmission and hospitalization in Kenya. Malar J 2010; 9: 285.
54. McElroy PD, Lal AA, Hawley WA, et al. Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project. Am J Trop Med Hyg 1999; 61: 932-940.
55. WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000; 94 ( Suppl 1): S1-S90.
56. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
57. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonic Int 2004; 11: 36-42.
58. Luty AJ, Perkins DJ, Lell B, et al. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun 2000; 68: 3909-3915.
59. Lyke KE, Diallo DA, Dicko A, et al. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am J Trop Med Hyg 2003; 69: 253-259.
60. Lee G. Anemia: General Aspects, 10th ed. Baltimore: Williams & Wilkins; 1999.
61. Were T, Hittner JB, Ouma C, et al. Suppression of RANTES in children with Plasmodium falciparum malaria. Haematologica 2006; 91: 1396-1399.
62. Andrade BB, Araujo-Santos T, Luz NF, et al. Heme impairs prostaglandin E2 and TGF-β production by human mononuclear cells via Cu/Zn superoxide dismutase: Insight into the pathogenesis of severe malaria. J Immunol 2010; 185: 1196-1204.
63. Ball HJ, MacDougall HG, McGregor IS, et al. Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. J Infect Dis 2004; 189: 751-758.
64. Deininger MH, Kremsner PG, Meyermann R, et al. Focal accumulation of cyclooxygenase-1 (COX-1) and COX-2 expressing cells in cerebral malaria. J Neuroimmunol 2000; 106: 198-205.
65. Xiao L, Patterson PS, Yang C, et al. Role of eicosanoids in the pathogenesis of murine cerebral malaria. Am J Trop Med Hyg 1999; 60: 668-673.
66. Datta MC. Prostaglandin E2 mediated effects on the synthesis of fetal and adult hemoglobin in blood erythroid bursts. Prostaglandins 1985; 29: 561-577.
67. Lamikanra AA, Brown D, Potocnik A, et al. Malarial anemia: Of mice and men. Blood 2007; 110: 18-28.
68. Ortega JA, Dukes PP, Ma A, et al. A clinical trial of prostaglandin E2 to increase erythropoiesis in anemia of end stage renal disease. A preliminary report. Prostaglandins Leukot Med 1984; 14: 411-416.
69. Kendall RG. Erythropoietin. Clin Lab Haematol 2001; 23: 71-80.
70. Boer AK, Drayer AL, Rui H, et al. Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB. Blood 2002; 100: 467-473.
71. Dukes PP, Shore NA, Hammond D, et al. Enhancement of erythropoiesis by prostaglandins. J Lab Clin Med 1973; 82: 704-712.
72. Dupuis F, Desplat V, Praloran V, et al. Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. J Lipid Mediat Cell Signal 1997; 16: 117-125.
73. Lorenz M, Slaughter HS, Wescott DM, et al. Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice. Exp Hematol 1999; 27: 1494-1502.
74. Oonishi T, Sakashita K, Ishioka N, et al. Production of prostaglandins E1 and E2 by adult human red blood cells. Prostaglandins Other Lipid Mediat 1998; 56: 89-101.
75. Rocca B, Secchiero P, Ciabattoni G, et al. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci USA 2002; 99: 7634-7639.
76. Allen JE, Rasmussen H. Human red blood cells: Prostaglandin E2, epinephrine, and isoproterenol alter deformability. Science 1971; 174: 512-514.
77. Burchard GD, Radloff P, Philipps J, et al. Increased erythropoietin production in children with severe malarial anemia. Am J Trop Med Hyg 1995; 53: 547-551.
78. Burgmann H, Looareesuwan S, Kapiotis S, et al. Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Am J Trop Med Hyg 1996; 54: 280-283.
79. Kurtzhals JA, Rodrigues O, Addae M, et al. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol 1997; 97: 169-174.
80. Nussenblatt V, Mukasa G, Metzger A, et al. Anemia and interleukin-10, tumor necrosis factor α, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria. Clin Diagn Lab Immunol 2001; 8: 1164-1170.
81. Casals-Pascual C, Roberts DJ. Severe malarial anaemia. Curr Mol Med 2006; 6: 155-168.
82. Haldar K, Murphy SC, Milner DA, et al. Malaria: Mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol 2007; 2: 217-249.
83. Fendel R, Brandts C, Rudat A, et al. Hemolysis is associated with low reticulocyte production index and predicts blood transfusion in severe malarial anemia. PLoS One 2010; 5: e10038.
84. Awandare GA, Kempaiah P, Ochiel DO, et al. Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model. Am J Hematol 2011; 86: 155-162.
85. Casals-Pascual C, Kai O, Cheung JO, et al. Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood 2006; 108: 2569-2577.
86. Giribaldi G, Ulliers D, Schwarzer E, et al. Hemozoin- and 4-hydroxynonenal-mediated inhibition of erythropoiesis. Possible role in malarial dyserythropoiesis and anemia. Haematologica 2004; 89: 492-493.
87. Lamikanra AA, Theron M, Kooij TW, et al. Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors. PLoS One 2009; 4: e8446.
88. Keller CC, Davenport GC, Dickman KR, et al. Suppression of prostaglandin E2 by malaria parasite products and antipyretics promotes overproduction of tumor necrosis factor-α: Association with the pathogenesis of childhood malarial anemia. J Infect Dis 2006; 193: 1384-1393.
89. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998; 38: 97-120.
90. Bippi H, Frolich JC. Effects of acetylsalicylic acid and paracetamol alone and in combination on prostanoid synthesis in man. Br J Clin Pharmacol 1990; 29: 305-310.
91. Reimann IW, Golbs E, Fischer C, et al. Influence of intravenous acetylsalicylic acid and sodium salicylate on human renal function and lithium clearance. Eur J Clin Pharmacol 1985; 29: 435-441.
92. Donnelly MT, Hawkey CJ. Review article: COX-II inhibitors-A new generation of safer NSAIDs? Aliment Pharmacol Ther 1997; 11: 227-236.
93. Vane JR. NSAIDs, Cox-2 inhibitors, and the gut. Lancet 1995; 346: 1105-1106.